A clinician-led, AI-native company rebuilding the riskiest stretch in medicine - the 30 days after you leave the hospital. It pairs licensed clinicians, called Transitionists, with a clinical AI named AiME.
In American medicine, an enormous amount of care is spent getting a patient safely through the hospital. Then, on discharge day, the system largely lets go. The patient walks out with a folder of instructions, a prescription or two, and a follow-up appointment weeks away. The next month - when incisions can turn, medications can clash, and warning signs go unread - is where recovery is often won or lost. It is also where the U.S. health system spends an estimated $52 to $62 billion a year on avoidable readmissions.
Dimer Health was built for that gap. Founded in 2023 and headquartered in Florham Park, New Jersey, the company runs a virtual medical practice dedicated to transitional care medicine - the clinical work of the first 30 days after a hospital stay. Instead of another app that tells patients to "call your doctor," Dimer supplies the doctor's team: licensed clinicians who stay connected from discharge through recovery, backed by real-time monitoring.
The company gives that clinician a name it is trying to make standard: the Transitionist. The idea has a precedent. The hospitalist - the doctor who manages your care while you are admitted - did not exist as a role before 1996. Today hospitalists are everywhere. Dimer's founders argue the same is about to happen one step downstream, in the home.
Within 24 to 72 hours of discharge, a Dimer Transitionist reaches the patient for a virtual visit, answering questions, reconciling medications, and watching for trouble. The relationship holds until the patient is steady enough to hand back to their primary care or specialty team. It is unglamorous work - phone calls, check-ins, symptom checks - and that is precisely the point.
The hospitalist did not exist before 1996. The Transitionist is next.
Dimer sells a dedicated clinical service line that plugs into existing systems and networks. Early adoption spans 28 health system facilities across eight states, with named partners including Atlantic Health System and Bergen New Bridge Medical Center in New Jersey.
The end users are patients recovering at home - after acute illness (pneumonia, Lyme, strep), chronic disease flares (heart failure, diabetes, kidney disease), or surgery (hernia repair, appendectomy, prostatectomy).
The window right after discharge drives an estimated $52-62B in annual U.S. readmission costs. It is high-risk and under-served: proactive medical oversight simply isn't standard once a patient leaves the building.
Dimer's bet is that people, not automation alone, close this gap - but people made far more scalable by AI that flags risk early. The clinician stays in charge; the software widens their reach.
AiME is Dimer's proprietary clinical AI. It engages patients in real time, interprets symptoms within the context of their medical history, and detects emerging risk signals. When something needs a human, it escalates - seamlessly - to a Transitionist. The design intent is telling: the AI's job is to know when to hand the patient to a clinician.
Licensed Transitionists deliver continuous medical oversight from discharge through recovery, embedded within health systems and payor networks.
Real-time patient engagement, symptom interpretation, risk detection, and escalation to human clinicians when intervention is warranted.
Bars are illustrative. 30% growth held for four consecutive quarters. Figures are company-reported.
Dimer is a virtual medical practice sold as a clinical service line to health systems and payors - not standalone software. Care is delivered by employed clinicians augmented by AiME, and the company accepts Medicare, Medicaid, and major commercial insurers. Value is tied to outcomes: fewer readmissions, better experience.
Many digital-health tools automate the patient away. Dimer keeps a licensed clinician at the center and uses AI to extend that clinician's reach and timing. Against remote-monitoring and post-acute players, its wedge is owning a defined clinical role - the Transitionist - end to end.
It sits near remote patient monitoring and post-acute management companies - the Cadence / Current Health / Biofourmis cohort - as well as traditional hospital case management and home health. Dimer's framing is narrower and role-based.
CEO Caroline Hodge is a former ER clinician and PA who led clinical operations at DocGo and Envision Healthcare. Co-founder Gidon Coussin is an emergency-medicine PA; Sarig Reichert built Wix Bookings. Medicine and consumer software, in one room.
Dimer is building the infrastructure for post-discharge care.
Caroline Hodge, Gidon Coussin, and Sarig Reichert launch in Florham Park, NJ to fix the hospital-to-home transition.
The clinician-led practice and proprietary clinical AI come together for real-time post-discharge monitoring.
Atlantic Health System and Bergen New Bridge Medical Center launch transitions-of-care programs with Dimer.
Team8 and Bill Ackman's Table Management lead the round, with Silver Circle and TechAviv. Total funding nears $20M; expansion goes national across eight states.
No official YouTube channel or product-demo video was found at time of publication. Facts drawn from public sources; company-reported metrics noted as such.